Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation

Detalles Bibliográficos
Autores principales: Spengler, Marianne, Wheelden, Megan, Mackley, Heath B., Drabick, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140788/
https://www.ncbi.nlm.nih.gov/pubmed/34036225
http://dx.doi.org/10.1200/PO.20.00486
_version_ 1783696244746485760
author Spengler, Marianne
Wheelden, Megan
Mackley, Heath B.
Drabick, Joseph J.
author_facet Spengler, Marianne
Wheelden, Megan
Mackley, Heath B.
Drabick, Joseph J.
author_sort Spengler, Marianne
collection PubMed
description
format Online
Article
Text
id pubmed-8140788
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-81407882021-05-24 Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation Spengler, Marianne Wheelden, Megan Mackley, Heath B. Drabick, Joseph J. JCO Precis Oncol Case Reports Wolters Kluwer Health 2021-04-19 /pmc/articles/PMC8140788/ /pubmed/34036225 http://dx.doi.org/10.1200/PO.20.00486 Text en © 2021 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Case Reports
Spengler, Marianne
Wheelden, Megan
Mackley, Heath B.
Drabick, Joseph J.
Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
title Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
title_full Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
title_fullStr Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
title_full_unstemmed Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
title_short Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation
title_sort durable major response with pazopanib in recurrent, heavily pretreated metastatic esthesioneuroblastoma harboring a fumarate hydratase mutation
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140788/
https://www.ncbi.nlm.nih.gov/pubmed/34036225
http://dx.doi.org/10.1200/PO.20.00486
work_keys_str_mv AT spenglermarianne durablemajorresponsewithpazopanibinrecurrentheavilypretreatedmetastaticesthesioneuroblastomaharboringafumaratehydratasemutation
AT wheeldenmegan durablemajorresponsewithpazopanibinrecurrentheavilypretreatedmetastaticesthesioneuroblastomaharboringafumaratehydratasemutation
AT mackleyheathb durablemajorresponsewithpazopanibinrecurrentheavilypretreatedmetastaticesthesioneuroblastomaharboringafumaratehydratasemutation
AT drabickjosephj durablemajorresponsewithpazopanibinrecurrentheavilypretreatedmetastaticesthesioneuroblastomaharboringafumaratehydratasemutation

Ejemplares similares